DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.22
-0.10 (-1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 15.65 | 3.03 | 4.54 | 4.73 | 4.71 | Upgrade
|
| Short-Term Investments | 44.24 | 41.12 | 48.35 | 28.77 | 40.41 | Upgrade
|
| Cash & Short-Term Investments | 59.89 | 44.15 | 52.9 | 33.5 | 45.11 | Upgrade
|
| Cash Growth | 35.66% | -16.54% | 57.89% | -25.74% | 64.00% | Upgrade
|
| Other Receivables | 0.26 | 0.24 | 0.37 | 0.08 | 0.13 | Upgrade
|
| Receivables | 0.26 | 0.24 | 0.37 | 0.08 | 0.13 | Upgrade
|
| Prepaid Expenses | 0.48 | 0.23 | 0.41 | 0.21 | 0.08 | Upgrade
|
| Other Current Assets | - | - | - | 0.04 | 0.11 | Upgrade
|
| Total Current Assets | 60.63 | 44.61 | 53.68 | 33.84 | 45.44 | Upgrade
|
| Property, Plant & Equipment | 0.34 | 0.43 | 0.49 | 0.56 | 0.11 | Upgrade
|
| Long-Term Deferred Charges | 0.4 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | 1.31 | - | - | - | Upgrade
|
| Total Assets | 61.37 | 46.35 | 54.16 | 34.4 | 45.55 | Upgrade
|
| Accounts Payable | 1.48 | 0.94 | 0.93 | 0.73 | 0.51 | Upgrade
|
| Accrued Expenses | 3.55 | 4.35 | 1.78 | 1.37 | 0.97 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.1 | 0.08 | 0.07 | 0.05 | Upgrade
|
| Total Current Liabilities | 5.13 | 5.39 | 2.79 | 2.17 | 1.52 | Upgrade
|
| Long-Term Leases | 0.13 | 0.24 | 0.32 | 0.4 | 0 | Upgrade
|
| Total Liabilities | 5.26 | 5.63 | 3.1 | 2.57 | 1.53 | Upgrade
|
| Additional Paid-In Capital | 228.83 | 180.7 | 166.61 | 128.08 | 126.58 | Upgrade
|
| Retained Earnings | -172.77 | -140 | -115.56 | -96.18 | -82.5 | Upgrade
|
| Comprehensive Income & Other | 0.05 | 0.02 | 0.01 | -0.07 | -0.05 | Upgrade
|
| Shareholders' Equity | 56.11 | 40.72 | 51.06 | 31.83 | 44.02 | Upgrade
|
| Total Liabilities & Equity | 61.37 | 46.35 | 54.16 | 34.4 | 45.55 | Upgrade
|
| Total Debt | 0.24 | 0.34 | 0.4 | 0.47 | 0.05 | Upgrade
|
| Net Cash (Debt) | 59.65 | 43.81 | 52.5 | 33.03 | 45.06 | Upgrade
|
| Net Cash Growth | 36.17% | -16.55% | 58.92% | -26.69% | 64.52% | Upgrade
|
| Net Cash Per Share | 1.27 | 1.08 | 1.61 | 1.25 | 2.17 | Upgrade
|
| Filing Date Shares Outstanding | 53.88 | 42.86 | 37.96 | 26.46 | 26.44 | Upgrade
|
| Total Common Shares Outstanding | 53.74 | 42.82 | 37.96 | 26.44 | 26.44 | Upgrade
|
| Working Capital | 55.5 | 39.22 | 50.89 | 31.67 | 43.92 | Upgrade
|
| Book Value Per Share | 1.04 | 0.95 | 1.35 | 1.20 | 1.66 | Upgrade
|
| Tangible Book Value | 56.11 | 40.72 | 51.06 | 31.83 | 44.02 | Upgrade
|
| Tangible Book Value Per Share | 1.04 | 0.95 | 1.35 | 1.20 | 1.66 | Upgrade
|
| Machinery | 0.28 | 0.25 | 0.22 | 0.2 | 0.14 | Upgrade
|
| Leasehold Improvements | 0.02 | 0.02 | 0.02 | 0.02 | 0 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.